Login / Signup
Fan Guo
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 7
Top Topics
Inflammatory Response
High Glucose
Binding Protein
Acute Kidney Injury
Top Venues
Cell death & disease
Signal transduction and targeted therapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Li Wen
,
Qian Ren
,
Fan Guo
,
Xiaoyan Du
,
Hongliu Yang
,
Ping Fu
,
Liang Ma
Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury.
Cell death & disease
14 (1) (2023)
Li Wen
,
Qian Ren
,
Fan Guo
,
Xiaoyan Du
,
Hongliu Yang
,
Ping Fu
,
Liang Ma
Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury.
Cell death & disease
14 (1) (2023)
Li Wen
,
Qian Ren
,
Fan Guo
,
Xiaoyan Du
,
Hongliu Yang
,
Ping Fu
,
Liang Ma
Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury.
Cell death & disease
14 (1) (2023)
Li Wen
,
Qian Ren
,
Fan Guo
,
Xiaoyan Du
,
Hongliu Yang
,
Ping Fu
,
Liang Ma
Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury.
Cell death & disease
14 (1) (2023)
Li Wen
,
Qian Ren
,
Fan Guo
,
Xiaoyan Du
,
Hongliu Yang
,
Ping Fu
,
Liang Ma
Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury.
Cell death & disease
14 (1) (2023)
Bo Wang
,
Jun Xu
,
Qian Ren
,
Lu Cheng
,
Fan Guo
,
Yan Liang
,
Letian Yang
,
Zhouke Tan
,
Ping Fu
,
Liang Ma
Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis.
Cell death & disease
13 (4) (2022)
Letian Yang
,
Bo Wang
,
Fan Guo
,
Rongshuang Huang
,
Yan Liang
,
Lingzhi Li
,
Sibei Tao
,
Ting Yin
,
Ping Fu
,
Liang Ma
FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury.
Signal transduction and targeted therapy
7 (1) (2022)